Serum and plasma neutrophil gelatinase associated lipocalin (NGAL) levels are not equivalent in patients admitted to intensive care
- PMID: 24395189
- PMCID: PMC6807606
- DOI: 10.1002/jcla.21662
Serum and plasma neutrophil gelatinase associated lipocalin (NGAL) levels are not equivalent in patients admitted to intensive care
Abstract
Background: Neutrophil gelatinase associated lipocalin (NGAL) is proposed as a biomarker of acute kidney injury (AKI). NGAL has been studied in a range of body fluids including serum and EDTA plasma. The aim of the present study was to establish relationship between serum NGAL concentrations and EDTA plasma NGAL concentrations in patients admitted to intensive care units (ICUs) and whether these determinations are directly comparable in this setting.
Methods: NGAL was measured in 40 paired samples of serum and EDTA plasma from 25 patients admitted to intensive care with a commercial particle-enhanced turbidimetric immunoassay (The NGAL Test™, BioPorto Diagnostics A/S, Gentofte, Denmark) on a Roche Hitachi 917 (Roche-Hitachi, Inc., Tokyo, Japan) analyzer.
Results: Serum NGAL concentrations ranged from 26.8 to 1,808 ng/ml (median 281 ng/ml, interquartile range (IQR) 453 ng/ml). EDTA plasma NGAL concentrations ranged from 25.7 to 1,752 ng/ml (median 225 ng/ml, IQR 352 ng/ml). The difference in NGAL concentrations in paired serum and EDTA plasma samples (serum- plasma) ranged from -13.8 to 321 ng/ml (median 79 ng/ml, IQR 116 ng/ml; difference from zero, P < 0.0001, Wilcoxon's signed rank test). Although serum and EDTA plasma values were correlated (Spearman's r = 0.95, P < 0.0001), Deming regression analysis showed a slope of 1.1 that was not significantly different from unity (95% confidence interval (CI) 1.0-1.1) and a highly significant intercept of 67.9 ng/ml with a wide confidence interval (95% CI 29.8-106).
Conclusion: NGAL concentration values measured in serum and EDTA plasma cannot be directly compared and should not be used as equivalents in studies of patients admitted to intensive care.
Keywords: acute kidney injury; biomarkers; critical illness; neutrophil gelatinase-associated lipocalin (NGAL); plasma; serum.
© 2014 Wiley Periodicals, Inc.
Figures

Similar articles
-
Serum neutrophil gelatinase-associated lipocalin at inception of renal replacement therapy predicts survival in critically ill patients with acute kidney injury.Crit Care. 2010;14(1):R9. doi: 10.1186/cc8861. Epub 2010 Feb 1. Crit Care. 2010. PMID: 20122150 Free PMC article.
-
Evaluation of NGAL TestTM on Cobas 6000.Scand J Clin Lab Invest. 2014 Jan;74(1):20-6. doi: 10.3109/00365513.2013.855943. Epub 2013 Nov 15. Scand J Clin Lab Invest. 2014. PMID: 24228725
-
Serum neutrophil gelatinase-associated lipocalin (NGAL) as a marker of acute kidney injury in critically ill children with septic shock.Crit Care Med. 2008 Apr;36(4):1297-303. doi: 10.1097/CCM.0b013e318169245a. Crit Care Med. 2008. PMID: 18379258 Free PMC article.
-
Neutrophil gelatinase associated lipocalin as a biomarker for acute kidney injury in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass.Ann Vasc Surg. 2010 May;24(4):525-31. doi: 10.1016/j.avsg.2010.01.001. Epub 2010 Apr 2. Ann Vasc Surg. 2010. PMID: 20363104 Review.
-
Diagnostic value of neutrophil gelatinase-associated lipocalin for early diagnosis of cardiac surgery-associated acute kidney injury: a meta-analysis.Eur J Cardiothorac Surg. 2016 Mar;49(3):746-55. doi: 10.1093/ejcts/ezv199. Epub 2015 Jun 20. Eur J Cardiothorac Surg. 2016. PMID: 26094017 Review.
Cited by
-
Validation of plasma neutrophil gelatinase-associated lipocalin as a biomarker for diabetes-related acute kidney injury.Sci Prog. 2024 Oct-Dec;107(4):368504241288776. doi: 10.1177/00368504241288776. Sci Prog. 2024. PMID: 39360481 Free PMC article.
-
Novel bone metabolism-associated hormones: the importance of the pre-analytical phase for understanding their physiological roles.Endocrine. 2017 Jun;56(3):460-484. doi: 10.1007/s12020-017-1239-z. Epub 2017 Feb 8. Endocrine. 2017. PMID: 28181144 Review.
-
Plasma neutrophil gelatinase-associated lipocalin predicts acute pyelonephritis in children with urinary tract infections.Pediatr Res. 2015 Jul;78(1):48-55. doi: 10.1038/pr.2015.59. Epub 2015 Mar 19. Pediatr Res. 2015. PMID: 25790277
-
Evolution of glomerular filtration rates and neutrophil gelatinase-associated lipocalin during treatment with direct acting antivirals.Clin Mol Hepatol. 2018 Jun;24(2):151-162. doi: 10.3350/cmh.2017.0059. Epub 2018 Apr 24. Clin Mol Hepatol. 2018. PMID: 29684978 Free PMC article.
-
A Multimodal Fuzzy Approach in Evaluating Pediatric Chronic Kidney Disease Using Kidney Biomarkers.Diagnostics (Basel). 2024 Jul 30;14(15):1648. doi: 10.3390/diagnostics14151648. Diagnostics (Basel). 2024. PMID: 39125525 Free PMC article.
References
-
- Clerico A, Galli C, Fortunato A, et al. Neutrophil gelatinase‐associated lipocalin (NGAL) as biomarker of acute kidney injury: A review of the laboratory characteristics and clinical evidences. Clin Chem Lab Med 2012;50:1505–1517. - PubMed
-
- Kjeldsen L, Johnsen AH, Sengeløv H, et al. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 1993;268:10425–10432. - PubMed
-
- Kjeldsen L, Bainton DF, Sengeløv H, et al. Identification of neutrophil gelatinase‐associated lipocalin as a novel matrix protein of specific granules in human neutrophils. Blood 1994;83:799–807. - PubMed
-
- Kjeldsen L, Cowland JB, Borregaard N. Human neutrophil gelatinase‐associated lipocalin and homologous proteins in rat and mouse. Biochim Biophys Acta 2000;1482:272–283. - PubMed
-
- Haase M, Bellomo R, Devarajan P, et al. Accuracy of neutrophil gelatinase‐associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: A systematic review and meta‐analysis. Am J Kidney Dis 2009;54:1012–1024. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous